Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H18F3N3O6 |
Molecular Weight | 441.3579 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)NC1=CC=C(OC[C@](C)(O)C(=O)NC2=CC=C(C(=C2)C(F)(F)F)[N+]([O-])=O)C=C1
InChI
InChIKey=YVXVTLGIDOACBJ-SFHVURJKSA-N
InChI=1S/C19H18F3N3O6/c1-11(26)23-12-3-6-14(7-4-12)31-10-18(2,28)17(27)24-13-5-8-16(25(29)30)15(9-13)19(20,21)22/h3-9,28H,10H2,1-2H3,(H,23,26)(H,24,27)/t18-/m0/s1
Molecular Formula | C19H18F3N3O6 |
Molecular Weight | 441.3579 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12604714Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/15308613 http://adisinsight.springer.com/drugs/800019485
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12604714
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/15308613 http://adisinsight.springer.com/drugs/800019485
Andarine is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy. Andarine is a selective non-steroidal androgen receptor (AR) agonist with Ki of 4 nM, tissue-selective for anabolic organs. Andarine had been in phase I clinical trials by GTx for the treatment of cancer-related cachexia and osteoporosis. However, this research has been discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16815963
Dogs: An intravenous (i.v.) bolus dose of 10 or 3 mg/kg, an oral(p.o.) solution dose of 10 mg/kg, or an oral capsule dose of 10 mg/kgadministered in a packed gelatin capsule
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12604714
Andarine stimulates AR-mediated transcription to 93% of that observed for 1 nM DHT at a concentration of 10 nM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:42:25 GMT 2023
by
admin
on
Fri Dec 15 15:42:25 GMT 2023
|
Record UNII |
7UT2HAH49H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Andarine
Created by
admin on Fri Dec 15 15:42:25 GMT 2023 , Edited by admin on Fri Dec 15 15:42:25 GMT 2023
|
||
|
DSLD |
4029 (Number of products:6)
Created by
admin on Fri Dec 15 15:42:25 GMT 2023 , Edited by admin on Fri Dec 15 15:42:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB07423
Created by
admin on Fri Dec 15 15:42:25 GMT 2023 , Edited by admin on Fri Dec 15 15:42:25 GMT 2023
|
PRIMARY | |||
|
DTXSID40193187
Created by
admin on Fri Dec 15 15:42:25 GMT 2023 , Edited by admin on Fri Dec 15 15:42:25 GMT 2023
|
PRIMARY | |||
|
7UT2HAH49H
Created by
admin on Fri Dec 15 15:42:25 GMT 2023 , Edited by admin on Fri Dec 15 15:42:25 GMT 2023
|
PRIMARY | |||
|
401900-40-1
Created by
admin on Fri Dec 15 15:42:25 GMT 2023 , Edited by admin on Fri Dec 15 15:42:25 GMT 2023
|
PRIMARY | |||
|
ANDARINE
Created by
admin on Fri Dec 15 15:42:25 GMT 2023 , Edited by admin on Fri Dec 15 15:42:25 GMT 2023
|
PRIMARY | |||
|
9824562
Created by
admin on Fri Dec 15 15:42:25 GMT 2023 , Edited by admin on Fri Dec 15 15:42:25 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |